145 related articles for article (PubMed ID: 21862569)
21. A pharmacogenetic-driven approach for controlled ovarian hyperstimulation by FSH treatment.
Colognato R; Aiello R; Dulcetti F; Ruggeri AM; De Toffol S; Marcato L; Irollo AM; Criscuolo C; Gangale MF; Maggi F; Simoni G
Minerva Ginecol; 2014 Dec; 66(6):543-9. PubMed ID: 25373014
[TBL] [Abstract][Full Text] [Related]
22. A spontaneous luteinizing hormone surge is beneficial in women with unexplained infertility undergoing controlled ovarian hyperstimulation without in vitro fertilization.
Costello MF; Hughes GJ; Garrett DK; Hanjani A; Steigrad SJ
Int J Fertil Womens Med; 1998; 43(1):28-33. PubMed ID: 9532467
[TBL] [Abstract][Full Text] [Related]
23. New tools for optimizing endometrial receptivity in controlled ovarian hyperstimulation: aromatase inhibitors and LH/(mini)hCG.
de Ziegler D; Mattenberger C; Schwarz C; Ibecheole V; Fournet N; Bianchi-Demicheli F
Ann N Y Acad Sci; 2004 Dec; 1034():262-77. PubMed ID: 15731318
[TBL] [Abstract][Full Text] [Related]
24. Aromatase inhibition reduces the dose of gonadotropin required for controlled ovarian hyperstimulation.
Mitwally MF; Casper RF
J Soc Gynecol Investig; 2004 Sep; 11(6):406-15. PubMed ID: 15350255
[TBL] [Abstract][Full Text] [Related]
25. Pharmacogenomics in IVF: A New Era in the Concept of Personalized Medicine.
Kalinderi K; Asimakopoulos B; Nikolettos N; Manolopoulos VG
Reprod Sci; 2019 Oct; 26(10):1313-1325. PubMed ID: 29587614
[TBL] [Abstract][Full Text] [Related]
26. Estradiol production during controlled ovarian hyperstimulation correlates with treatment outcome in women undergoing in vitro fertilization-embryo transfer.
Mitwally MF; Bhakoo HS; Crickard K; Sullivan MW; Batt RE; Yeh J
Fertil Steril; 2006 Sep; 86(3):588-96. PubMed ID: 16814289
[TBL] [Abstract][Full Text] [Related]
27. FSH receptor, KL1/2, P450, and PAPP genes in granulosa-lutein cells from in vitro fertilization patients show a different expression pattern depending on the infertility diagnosis.
González-Fernández R; Peña O; Hernández J; Martín-Vasallo P; Palumbo A; Avila J
Fertil Steril; 2010 Jun; 94(1):99-104. PubMed ID: 19342032
[TBL] [Abstract][Full Text] [Related]
28. Programming in vitro fertilization retrievals during working days after a gonadotropin-releasing hormone antagonist protocol with estrogen pretreatment: does the length of exposure to estradiol impact on controlled ovarian hyperstimulation outcomes?
Guivarc'h-Levêque A; Homer L; Arvis P; Broux PL; Moy L; Priou G; Vialard J; Colleu D; Dewailly D
Fertil Steril; 2011 Oct; 96(4):872-6. PubMed ID: 21868004
[TBL] [Abstract][Full Text] [Related]
29. Patients with endometriosis and patients with poor ovarian reserve have abnormal follicle-stimulating hormone receptor signaling pathways.
González-Fernández R; Peña Ó; Hernández J; Martín-Vasallo P; Palumbo A; Ávila J
Fertil Steril; 2011 Jun; 95(7):2373-8. PubMed ID: 21474127
[TBL] [Abstract][Full Text] [Related]
30. Association between the luteinizing hormone/chorionic gonadotropin receptor (LHCGR) rs4073366 polymorphism and ovarian hyperstimulation syndrome during controlled ovarian hyperstimulation.
O'Brien TJ; Kalmin MM; Harralson AF; Clark AM; Gindoff I; Simmens SJ; Frankfurter D; Gindoff P
Reprod Biol Endocrinol; 2013 Jul; 11():71. PubMed ID: 23883350
[TBL] [Abstract][Full Text] [Related]
31. [Ovarian stimulation with various FSH/LH concentrations in an in vitro fertilization program].
Diedrich K; Diedrich C; Germer U; Bauer O; al-Hasani S; Krebs D; Kleber E
Geburtshilfe Frauenheilkd; 1994 Mar; 54(3):167-70. PubMed ID: 8188016
[TBL] [Abstract][Full Text] [Related]
32. ESR1 and ESR2 gene polymorphisms are associated with human reproduction outcomes in Brazilian women.
de Mattos CS; Trevisan CM; Peluso C; Adami F; Cordts EB; Christofolini DM; Barbosa CP; Bianco B
J Ovarian Res; 2014 Dec; 7():114. PubMed ID: 25526766
[TBL] [Abstract][Full Text] [Related]
33. Ovulation induction in IVF.
Oehninger S
Minerva Ginecol; 2011 Apr; 63(2):137-56. PubMed ID: 21508903
[TBL] [Abstract][Full Text] [Related]
34. Ovarian stimulation and emergency in vitro fertilization for fertility preservation in cancer patients.
Michaan N; Ben-David G; Ben-Yosef D; Almog B; Many A; Pauzner D; Lessing JB; Amit A; Azem F
Eur J Obstet Gynecol Reprod Biol; 2010 Apr; 149(2):175-7. PubMed ID: 20074845
[TBL] [Abstract][Full Text] [Related]
35. Association of a promoter polymorphism in FSHR with ovarian reserve and response to ovarian stimulation in women undergoing assisted reproductive treatment.
Tohlob D; Abo Hashem E; Ghareeb N; Ghanem M; Elfarahaty R; Byers H; Pemberton P; Roberts SA; Newman WG; Mohiyiddeen L
Reprod Biomed Online; 2016 Sep; 33(3):391-7. PubMed ID: 27448492
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of recombinant human follicle-stimulating hormone in improving oocyte quality in assisted reproductive techniques.
Cheon KW; Byun HK; Yang KM; Song IO; Choi KH; Yoo KJ
J Reprod Med; 2004 Sep; 49(9):733-8. PubMed ID: 15493565
[TBL] [Abstract][Full Text] [Related]
37. Women with advanced-stage endometriosis and previous surgery respond less well to gonadotropin stimulation, but have similar IVF implantation and delivery rates compared with women with tubal factor infertility.
Matalliotakis IM; Cakmak H; Mahutte N; Fragouli Y; Arici A; Sakkas D
Fertil Steril; 2007 Dec; 88(6):1568-72. PubMed ID: 17349642
[TBL] [Abstract][Full Text] [Related]
38. Small doses of LH activity are needed early in ovarian stimulation for better quality oocytes in IVF-ET.
Drakakis P; Loutradis D; Kallianidis K; Liapi A; Milingos S; Makrigiannakis A; Dionyssiou-Asteriou A; Michalas S
Eur J Obstet Gynecol Reprod Biol; 2005 Jul; 121(1):77-80. PubMed ID: 15989987
[TBL] [Abstract][Full Text] [Related]
39. Effects of salpingectomy on ovarian response in controlled ovarian hyperstimulation for in vitro fertilization: a reappraisal.
Almog B; Wagman I; Bibi G; Raz Y; Azem F; Groutz A; Barkan G; Holzer H; Amit A; Tulandi T; Levin I
Fertil Steril; 2011 Jun; 95(8):2474-6. PubMed ID: 21474129
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the efficacy and safety of a new recombinant human follicle-stimulating hormone (DA-3801) with follitropin-alpha (Gonal-F) in women undergoing controlled ovarian hyperstimulation for assisted reproductive technology.
Moon SY; Choi YS; Ku SY; Kim SH; Choi YM; Kang IS; Kim CH
J Obstet Gynaecol Res; 2007 Jun; 33(3):305-15. PubMed ID: 17578360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
